|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/16/21 India Globalization Capital, Inc. 10-Q 12/31/20 84:5.2M Federal Filings, LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 498K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 28K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
11: R1 Document And Entity Information HTML 51K
12: R2 Condensed Consolidated Balance Sheets HTML 116K
13: R3 Condensed Consolidated Balance Sheets HTML 40K
(Parentheticals)
14: R4 Condensed Consolidated Statements of Operations HTML 75K
and Comprehensive Loss
15: R5 Condensed Consolidated Statement of Stockholders? HTML 71K
Equity
16: R6 Condensed Consolidated Statements of Cash Flows HTML 95K
17: R7 Business Description HTML 31K
18: R8 Summary of Significant Accounting Policies HTML 74K
19: R9 Inventory HTML 36K
20: R10 Deposits and Advances HTML 38K
21: R11 Intangible Assets HTML 54K
22: R12 Property, Plant and Equipment, Net HTML 54K
23: R13 Investments in Non-Marketable Securities HTML 34K
24: R14 Claims and Advances HTML 36K
25: R15 Leases HTML 61K
26: R16 Accrued and Other Liabilities HTML 35K
27: R17 Loans and Other Liabilities HTML 29K
28: R18 Commitments and Contingencies HTML 27K
29: R19 Securities HTML 27K
30: R20 Stock-Based Compensation HTML 66K
31: R21 Fair Value of Financial Instruments HTML 83K
32: R22 Segment Information HTML 119K
33: R23 Subsequent Events HTML 26K
34: R24 Accounting Policies, by Policy (Policies) HTML 113K
35: R25 Summary of Significant Accounting Policies HTML 41K
(Tables)
36: R26 Inventory (Tables) HTML 35K
37: R27 Deposits and Advances (Tables) HTML 38K
38: R28 Intangible Assets (Tables) HTML 56K
39: R29 Property, Plant and Equipment, Net (Tables) HTML 54K
40: R30 Investments in Non-Marketable Securities (Tables) HTML 34K
41: R31 Claims and Advances (Tables) HTML 36K
42: R32 Leases (Tables) HTML 66K
43: R33 Accrued and Other Liabilities (Tables) HTML 35K
44: R34 Stock-Based Compensation (Tables) HTML 69K
45: R35 Fair Value of Financial Instruments (Tables) HTML 81K
46: R36 Segment Information (Tables) HTML 118K
47: R37 Business Description (Details) HTML 26K
48: R38 Summary of Significant Accounting Policies HTML 33K
(Details)
49: R39 Summary of Significant Accounting Policies HTML 42K
(Details) - Disaggregation of Revenue
50: R40 Inventory (Details) HTML 27K
51: R41 Inventory (Details) - Schedule of Inventory, HTML 31K
Current
52: R42 DEPOSITS AND ADVANCES (Details) - Deferred Costs, HTML 35K
Capitalized, Prepaid, and Other Assets Disclosure
53: R43 Intangible Assets (Details) HTML 33K
54: R44 Intangible Assets (Details) - Schedule of HTML 46K
Intangible Assets And Goodwill
55: R45 Intangible Assets (Details) - Schedule of HTML 34K
Finite-Lived Intangible Assets, Future
Amortization Expense
56: R46 Property, Plant and Equipment, Net (Details) HTML 25K
57: R47 Property, Plant and Equipment, Net (Details) - HTML 59K
Property, Plant and Equipment
58: R48 Investments in Non-Marketable Securities (Details) HTML 24K
59: R49 Investments in Non-Marketable Securities (Details) HTML 30K
- Schedule of Investments
60: R50 Claims and Advances (Details) HTML 27K
61: R51 Claims and Advances (Details) - Schedule of Other HTML 32K
Assets, Noncurrent
62: R52 Leases (Details) HTML 32K
63: R53 Leases (Details) - Lease, Cost HTML 32K
64: R54 Leases (Details) - Lessee, Operating Lease, HTML 39K
Disclosure
65: R55 Leases (Details) - Lessee, Operating Lease, HTML 40K
Liability, Maturity
66: R56 Accrued and Other Liabilities (Details) HTML 27K
67: R57 Accrued and Other Liabilities (Details) - Schedule HTML 33K
of Accounts Payable and Accrued Liabilities
68: R58 Loans and Other Liabilities (Details) HTML 54K
69: R59 Commitments and Contingencies (Details) HTML 26K
70: R60 Securities (Details) HTML 50K
71: R61 Stock-Based Compensation (Details) HTML 52K
72: R62 Stock-Based Compensation (Details) - Schedule of HTML 35K
Share-based Payment Award, Stock Options,
Valuation Assumptions
73: R63 Stock-Based Compensation (Details) - Nonvested HTML 42K
Restricted Stock Shares Activity
74: R64 Stock-Based Compensation (Details) - Share-based HTML 51K
Payment Arrangement, Option, Activity
75: R65 Fair Value of Financial Instruments (Details) HTML 28K
76: R66 Fair Value of Financial Instruments (Details) - HTML 48K
Schedule of Fair Value, Assets and Liabilities
Measured on Recurring Basis
77: R67 Segment Information (Details) HTML 27K
78: R68 Segment Information (Details) - Revenue from HTML 36K
External Customers by Products and Services
79: R69 Segment Information (Details) - Revenue from HTML 40K
External Customers by Geographic Areas
80: R70 Segment Information (Details) - Schedule of HTML 48K
Revenue from External Customers and Long-Lived
Assets, by Geographical Areas
81: R71 Subsequent Events (Details) HTML 28K
83: XML IDEA XML File -- Filing Summary XML 158K
82: EXCEL IDEA Workbook of Financial Reports XLSX 97K
5: EX-101.INS XBRL Instance -- igc-20201231 XML 1.27M
7: EX-101.CAL XBRL Calculations -- igc-20201231_cal XML 132K
8: EX-101.DEF XBRL Definitions -- igc-20201231_def XML 608K
9: EX-101.LAB XBRL Labels -- igc-20201231_lab XML 1.09M
10: EX-101.PRE XBRL Presentations -- igc-20201231_pre XML 606K
6: EX-101.SCH XBRL Schema -- igc-20201231 XSD 164K
84: ZIP XBRL Zipped Folder -- 0001185185-21-000201-xbrl Zip 153K
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 17 CFR 240.13(a)-14(a)
(SECTION 302 CERTIFICATION)
I, Ram Mukunda, certify that:
|
1. |
I have reviewed this quarterly report on Form 10-Q of India Globalization Capital, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The Registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c. |
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d. |
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
|
5. |
The Registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
|
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
|
Date: February 12, 2021 |
By: |
/s/ Ram Mukunda |
|
|
|
|
|
|
|
President and Chief Executive Officer (Principal Executive Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 2/16/21 | |||
| Filed on: | 2/12/21 | |||
| For Period end: | 12/31/20 | CORRESP, UPLOAD | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/22/21 IGC Pharma, Inc. POS AM 4:206K Federal Filings, LLC/FA |